This study indicates that the impaired mitochondrial function may be a barrier to tumorigenesis by activating p53 in oncocytomas, while subsequent alterations of p53 and other nuclear genes lead to malignant ChRCC. Here, TP53 is linked to chromophobe renal cell carcinoma.